シャーガス病治療薬の世界市場 - 流通チャネル別 (病院薬局、小売薬局)：産業分析・動向・展望・機会分析 (2022年～2028年)

シャーガス病は熱帯性の寄生虫病で、ラテンアメリカの21ヶ国に蔓延しています。シャーガス病は中南米の風土病ですが、近年、中南米の人々が他国へ移住することにより、世界的に発生率が上昇しています。現在、シャーガス病の治療薬として使用できるのは、ベンズニダゾール (Benznidazole) とニフルチモックス (Nifurtimox) の2剤のみです。

当レポートでは、世界のシャーガス病治療薬の市場について分析し、市場の基本構造や促進・抑制要因、製品種類別・流通チャネル別・地域別の市場動向の見通し、主要企業のプロファイル・戦略などを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

• 分析概要
  • 市場の定義と範囲
• エグゼクティブサマリー
• COM (Coherent Opportunity Map)

第3章 市場の力学・規制・動向の分析

• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
• 診断の必要性
• 診断方法
• 最近の製品承認/上市
• パイプライン分析
• 規制シナリオ
• PEST分析
• 疫学

第4章 世界のシャーガス病治療薬市場：製品種類別 (単位：100万米ドル、2017年～2028年)

• イントロダクション
• 市場シェア：製品種類別 (%、2022年・2028年)
• 対前年成長率 (YoY)：製品種類別 (2017年～2028年)
• セグメント別の動向
  • ベンズニダゾール
  • ニフルチモックス
    • イントロダクション
    • 市場規模とその予測、対前年成長率 (YoY) (単位：100万米ドル、2017年～2028年)

第5章 世界のシャーガス病治療薬市場：流通チャネル別 (単位：100万米ドル、2017年～2028年)

• イントロダクション
• 市場シェア：流通チャネル別 (%、2022年・2028年)
• 対前年成長率 (YoY)：流通チャネル別 (2017年～2028年)
• セグメント別の動向
  • 病院
  • 小売薬局
  • オンライン薬局

第6章 世界のシャーガス病治療薬市場：地域別 (単位：100万米ドル、2017年～2028年)

• イントロダクション
• 市場シェア：地域別 (%、2022年・2028年)
• 対前年成長率 (YoY)：地域別 (2017年～2028年)
• 北米
  • イントロダクション
  • 市場規模とその予測：製品種類別 (単位：100万米ドル、2017年～2028年)
  • 市場規模とその予測：流通チャネル別 (単位：100万米ドル、2017年～2028年)
  • 市場規模とその予測：国別 (単位：100万米ドル、2017年～2028年)
  • 米国
  • カナダ
• 欧州
  • イントロダクション
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • 他の欧州諸国
• アジア太平洋
  • 日本
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • ボリビア
  • コロンビア
  • ベネズエラ
  • パラグアイ
  • 他のラテンアメリカ諸国

第7章 競合情勢

• ヒートマップ分析
• 企業プロファイル
  • Nortec Quimica SA
    • 企業概要
    • 製品ポートフォリオ
    • 主な動向
    • 財務実績
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed S.A.
  • Laboratorio Farmaceutico de Pernambuco S/A

第8章 付録

Chagas disease is a tropical parasitic disease and is endemic in 21 countries in Latin America. Chagas disease can transmitted through blood transfusion, organ transplantation, as well as congenital and oral transmissions. Chagas disease is endemic to Latin America, however, in the recent past, there is a rise in global incidence of Chagas disease due to the migration of Latin American people to other countries. According to data published by World Health Organization (WHO), in February 2018, globally, around 6 Mn to 7 Mn people were infected with Trypansosoma cruzi, the parasite which causes Chagas disease. Benznidazole and Nifurtimox are only two drugs available for the treatment of Chagas disease.

Market Dynamics

Rising migration of people from endemic countries to developed economies such as the U.S. and in countries in Europe is expected to drive growth of Chagas disease treatment market. For instance, according to the data published by Public Library of Science (PLOS), in 2012, there are around 1,62,095 Bolivian adults living in Spain, in which about 97,215 are women (60%) and 64,880 are men. It was estimated that out of total immigrants from Bolivia to Spain 34,202 were found to be potentially infected with Chagas disease. Furthermore, increasing R&D activities for the development of novel treatment methods for Chagas disease is also expected to create a lucrative environment for the market growth. For instance, in 2021, researchers from Saint Louis University Center for Vaccine Development were working on developing a vaccine for Chagas disease. Scientists found Th17 cells, a special type of white blood cell that recognizes the presence of a foreign invader and helps other cells in the immune system to attack and protects the body against Trypanosoma cruzi parasite.

Key features of the study:

• This report provides in-depth analysis of Chagas disease treatment market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Chagas disease treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratorio Farmaceutico de Pernambuco S/A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Chagas disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Chagas disease treatment market

Detailed Segmentation:

• Global Chagas Disease Treatment Market, By Product Type:
  • Benznidazole
  • Nifurtimox
• Global Chagas Disease Treatment Market, By Distribution Channel:
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
• Global Chagas Disease Treatment Market, By Geography:
  • North America
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.S.
    • Canada
  • Europe
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Japan
    • Australia
  • Latin America
    • By Product Type:
    • Benznidazole
    • Nifurtimox
    • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Bolivia
    • Columbia
    • Venezuela
    • Paraguay
    • Rest of Latin America
• Company Profiles
  • Nortec Quimica SA*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed S.A.
  • Laboratorio Farmaceutico de Pernambuco S/A

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Product Type
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Diagnosis Needs
• Diagnosis Methods
• Recent Product Approval/Launch
• Pipeline Analysis
• Regulatory Scenario
• PEST Analysis
• Epidemiology

4. Global Chagas Disease Treatment Market, By Product Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
• Benznidazole
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Nifurtimox
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Chagas Disease Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
• Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Chagas Disease Treatment Market, By Region, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, By Region, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• Japan
• Australia
• Latin America
• Introduction
• Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
• Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Bolivia
• Columbia
• Venezuela
• Paraguay
• Rest of Latin America

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
• Nortec Quimica SA
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Bayer AG
• Company Overview
• Product Portfolio
• Key Developments
• Strategies
• Laboratorio Elea Phoenix SA
• Company Overview
• Product Portfolio
• Key Developments
• Strategies
• Maprimed S.A.
• Company Overview
• Product Portfolio
• Manufacturing Capabilities
• Laboratorio Farmaceutico de Pernambuco S/A
• Company Overview
• Product Portfolio
• Strategies

8. Section

• Research Methodology
• About us and Sales Contact